Works matching IS 20965303 AND DT 2021 AND VI 4 AND IP 3

Results: 8

A case report of response to crizotinib in chemotherapy-refractory metastatic gallbladder cancer with met amplification and acquired resistance resulting from the loss of MET amplification.

Published in:

Precision Clinical Medicine, 2021, v. 4, n. 3, p. 209, doi. 10.1093/pcmedi/pbab017

By:

Hongna Sun;
Xiaofen Li;
Shuang Dai;
Xudong Shen;
Meng Qiu

Publication type:

Article

Identification and characteristic analysis of enhancers across 13 major cancer types.

Published in:

Precision Clinical Medicine, 2021, v. 4, n. 3, p. 204, doi. 10.1093/pcmedi/pbab019

By:

Mingming Qian;
Wenzhu Wang;
Yana Zhang;
Yi Zhao;
Huige Quan;
Yuting Chen;
Xinyue Dai;
Zhiyun Guo

Publication type:

Article

Understanding the predictive value and methods of risk assessment based on coronary computed tomographic angiography in populations with coronary artery disease: a review.

Published in:

Precision Clinical Medicine, 2021, v. 4, n. 3, p. 192, doi. 10.1093/pcmedi/pbab018

By:

Yiming Li;
Kaiyu Jia;
Yuheng Jia;
Yong Yang;
Yijun Yao;
Mao Chen;
Yong Peng

Publication type:

Article

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics.

Published in:

Precision Clinical Medicine, 2021, v. 4, n. 3, p. 179, doi. 10.1093/pcmedi/pbab014

By:

Wenyi Liu;
Luoxi Li;
Jianxin Jiang;
Min Wu;
Ping Lin

Publication type:

Article

Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do.

Published in:

Precision Clinical Medicine, 2021, v. 4, n. 3, p. 176, doi. 10.1093/pcmedi/pbab015

By:

Tao Yin

Publication type:

Article

CRISPR/Cas9 mediated somatic gene therapy for insertional mutations: the vibrator mouse model.

Published in:

Precision Clinical Medicine, 2021, v. 4, n. 3, p. 168, doi. 10.1093/pcmedi/pbab021

By:

Xin Fu;
Jie Zhu;
Yaou Duan;
Lu, Paul;
Kang Zhang

Publication type:

Article

The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera.

Published in:

Precision Clinical Medicine, 2021, v. 4, n. 3, p. 149, doi. 10.1093/pcmedi/pbab016

By:

Gen Li;
Zhongcheng Zhou;
Peng Du;
Meixing Yu;
Ning Li;
Xinxin Xiong;
Hong Huang;
Zhihai Liu;
Qinjin Dai;
Jie Zhu;
Chengbin Guo;
Shanyun Wu;
Baptista-Hon, Daniel T.;
Man Miao;
Lam Wai Ming;
Yong Wu;
Fanxin Zeng;
Zhang, Charlotte L.;
Zhang, Edward D.;
Haifeng Song

Publication type:

Article

CXCL13 expression in mouse 4T1 breast cancer microenvironment elicits antitumor immune response by regulating immune cell infiltration.

Published in:

Precision Clinical Medicine, 2021, v. 4, n. 3, p. 155, doi. 10.1093/pcmedi/pbab020

By:

Qizhi Ma;
Yue Chen;
Qing Qin;
Fuchun Guo;
Yong-sheng Wang;
Dan Li

Publication type:

Article